One paper [26] reviewing diabetic neuropathy included two RCTs [10,28] and concluded that ALC could relief neuropathic pain, while another paper reviewing HIV-associated neuropathy included one RCT [11] and suggested no superiority of ALC to placebo
Some did fit better, though
Abstract Ischemic stroke represents a dynamic metabolic disorder of the neurovascular unit (NVU) rather than a static vascular occlusion followed by neuronal demise
Its similar to insulin and works together with growth hormone to promote cell growth
Heres what the clinical evidence shows for FDA-approved medications: Semaglutide ( Wegovy ): In the STEP 1 trial, participants on weekly 2.4 mg semaglutide lost an average of about 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group
Blue Cross and Blue Shield of New Mexico does not dictate or direct providers in the practice of medicine, nor the exercise of medical judgment, nor making health care service treatment decisions